SOURCE: BioElectronics Corporation
May 26, 2009 03:00 ET
BioElectronics Corp. Appoints Charles Gregoire de Rothschild to Post of Special Adviser to Board
FREDERICK, MD--(Marketwire - May 26, 2009) - BioElectronics Corp. (PINKSHEETS: BIEL), the
maker of inexpensive, disposable drug-free anti-inflammatory devices, today
announced the appointment of international financier Charles Gregoire de
Rothschild to the role of Special Adviser to the Company's board of
directors. Mr. de Rothschild will support BioElectronics' continuing
global expansion efforts by leveraging his extensive domestic and
international financial expertise.
"I am a strong believer in BioElectronics Corporation's drug-free pain
relieving and healing products and see strong revenue and profit growth
over the coming years," commented Mr. de Rothschild. "I look forward to
helping the Company obtain the capital to allow movement of these exciting
products into the mainstream of medical technologies and in assisting in
the expansion of worldwide marketing and distribution."
"We are excited to be working with Mr. de Rothschild toward the goals of
expanding our capital base and acquiring additional international
distribution partnerships. We believe his proven track record as a highly
successful financier for growth companies, in addition to his strong
international contacts, will allow BioElectronics to move a step closer to
our goal of worldwide distribution for our advanced solutions for pain
management and healing."
Mr. de Rothschild, Chairman of GDR Privée, an international investment
boutique, has an extensive international banking background and has served
in many advisory roles.
About BioElectronics Corporation
BioElectronics Corporation is the maker of ActiPatch® Therapy,
RecoveryRx™ Devices, HealFast™ Therapy (www.healfasttherapy.com) and
the Allay™ family of inexpensive, disposable drug-free anti-inflammatory
devices. For more information please see http://www.BioElectronicsCorp.com.